Search results for: 'development bo58 iot'

Strategic imperatives are concepts that companies embrace to overcome internal and external challenges, such as economic disruptions that make it difficult to prepare a company for the future. Frost & Sullivan has identified eight: 1. Innovative Business Models 2. Compression of Value Chains 3. Transformative Megatrends 4. Disruptive Techn...

By 2023, biologics constituted 44% of the therapeutic pipeline, with antibodies and recombinant proteins as leading categories. Nevertheless, advancements in these fields decelerated, with most of the expansion happening in heterologous cell treatments, synthetic nucleic acids, and viruses. The global biologics pipeline will shift toward more compl...

Frost & Sullivan’s global IoT and Edge predictions for 2025 are based on insights gathered from our regional research teams. The contributions from research analysts leverage the extensive Frost & Sullivan knowledge base alongside both primary and secondary research.The report identifies the top 10 growth opportunities for 2025, encompassing analys...

Frost & Sullivan defines non-licensed low-power wide-area network (LPWAN) connection as active devices connected to a wireless communication network designed for low-bandwidth, long-range data transmission over an unlicensed spectrum. This type of technology connects IoT devices with low power consumption and low data rates and covers large areas. ...

In the post-pandemic scenario, city governments invest in the effective use of data to deliver efficient urban transport systems, a cleaner environment, robust urban infrastructure, and improve city dwellers' overall quality of life. Frost & Sullivan's IoT Building Smart Cities: Growth Opportunities for IoT Start-ups is a resource to help the ecosy...

The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% hike over 2022, with more than 6,100 molecules in active development. In general, however, the pharma/biopharma industry has stagnated with respect to R&D activity. Overall R&D expenditure totals about $276....

Wearables IoT devices are small electronic devices with wireless communication capabilities incorporated into gadgets, accessories, clothes worn on the human body, or invasive equipment. Wearable IoT devices are gaining popularity globally as they have enhanced the consumers’ quality of life and convenience. The wearable IoT device testing marke...

The convergence of IoT and healthcare, known as the internet of medical things (IoMT), is transforming the healthcare landscape, bringing unprecedented connectivity and convenience. However, the rapid proliferation of IoT devices in healthcare exposes critical data security and cybersecurity risks. This Frost & Sullivan study explores data security...

AI generative design technology is emerging as a transformative tool across various industries, including the automotive sector. The technology tool presents tremendous potential for innovation in automotive design by enabling OEMs to explore multiple design iterations swiftly and cost-effectively to produce more fuel-efficient, lightweight vehicle...